Michiel Koeijvoets

Michiel has over 21 years of drug development and clinical research experience in both pharma and CROs. He joined Fortrea in 2011 providing project management and delivery leadership oversight across many CVMER projects, from Phase I through Phase IV, including registrational and post-marketing programs. Michiel heads up the delivery team and overall accountable for the successful execution of the portfolio in cardiovascular, metabolic, endocrine and renal diseases. Michiel fosters relationships across the CVMER industry, including Fortrea’s sponsors and vendors, collaborating on their clinical development programs and understanding their key needs.